Detalles de la búsqueda
1.
Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry.
Breast Cancer Res Treat
; 187(3): 785-792, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33604714
2.
Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Cancer Sci
; 111(10): 3912-3925, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761968
3.
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
Ann Surg Oncol
; 26(8): 2409-2416, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31065958
4.
Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer.
Breast Cancer Res Treat
; 172(2): 425-436, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30132218
5.
The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women.
Ann Surg Oncol
; 22(11): 3481-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25652052
6.
Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
Breast Cancer Res Treat
; 148(1): 91-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25253173
7.
High volumetric breast density predicts risk for breast cancer in postmenopausal, but not premenopausal, Korean Women.
Ann Surg Oncol
; 21(13): 4124-32, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24934582
8.
Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
Ann Surg Oncol
; 21(4): 1254-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356798
9.
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR).
BMC Cancer
; 14: 170, 2014 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24612502
10.
Clinical Features of Li-Fraumeni Syndrome in Korea.
Cancer Res Treat
; 56(1): 334-341, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562436
11.
Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.
Ann Surg Oncol
; 20(5): 1505-13, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23192228
12.
Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.
BMC Cancer
; 13: 502, 2013 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24160266
13.
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor-Positive and HER-2-Negative Breast Cancer with Neoadjuvant Chemotherapy.
Cancer Res Treat
; 55(2): 542-550, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36097802
14.
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study.
Breast Cancer (Dove Med Press)
; 15: 251-261, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37081941
15.
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer.
Cancers (Basel)
; 15(18)2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760420
16.
A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer.
Invest New Drugs
; 30(5): 1972-7, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22006161
17.
Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer.
Invest New Drugs
; 30(1): 408-16, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20922557
18.
Stage-to-stage comparison of neoadjuvant chemotherapy versus adjuvant chemotherapy in pathological lymph node positive breast cancer patients.
Jpn J Clin Oncol
; 42(11): 995-1001, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22911001
19.
Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer.
Cancers (Basel)
; 14(5)2022 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267540
20.
Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to St Gallen consensus and intrinsic subtypes.
J Surg Oncol
; 103(3): 207-11, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21337548